Cardiometabolic Health Congress

OCTOBER 25, 2024

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64

CME Innovation Education Atherosclerosis 64

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. 101272, [link].

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

FEBRUARY 13, 2024

Previous to GWU, Earls served as Medical Director and Vice President at Fairfax Radiological Consultants (FRC) in Fairfax, VA, where he was an early innovator and clinical adopter of coronary CT angiography. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. In Press European Heart Journal CV Imag 2024.This James Min, M.D.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations. Exosomes from ASCs also play an indispensable role in this process.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

DAIC

MARCH 14, 2024

As a pioneer of HIV cardiology, her body of work continues to be multidisciplinary, innovative, and paradigm shifting in medicine.

COVID-19 105

COVID-19 Cardiovascular Disease Research Atherosclerosis 105

Stroke Journal

FEBRUARY 1, 2024

We propose these findings as a basis for designing a larger scale study for result confirmation.

Sickle Cell Disease 40

Sickle Cell Disease Innovation Thrombolysis Academic 40

Circulation

JANUARY 15, 2024

Coronary artery calcification (CAC) accompanies the development of advanced atherosclerosis. These innovations may speed achieving the ultimate goal of providing noninvasively specific and clinically actionable information. Circulation, Volume 149, Issue 3 , Page 251-266, January 16, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Cardiometabolic Health Congress

AUGUST 14, 2024

This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. With his support, CMHC has championed a vision of a brighter future for clinicians, patients, and the entire healthcare sector. Shapiro, DO Back By Popular Demand!

CME 72

CME Education Diabetes Innovation 72

Cardiometabolic Health Congress

DECEMBER 5, 2024

As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. Watch AI-ECHO results.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Circulation

NOVEMBER 11, 2024

a unique approach, we crossed DS model mice withApoE-null mice and fed them a high-fat diet (HFD) for 12 weeks to survey the effects of DS-related genes on atherosclerosis. This innovative method allowed us to observe a remarkable (~35%) reduction in ApoE-null mediated atheroma formation in the DS model.

Atherosclerosis 40

Atherosclerosis Diet Innovation Research 40

DAIC

APRIL 9, 2024

Technological innovations have made catheter ablation safer and more effective than ever before,” Tzeis, who added, “For example, we now have pulsed field ablation which uses high energy electrical pulses to treat atrial fibrillation without damaging the nerves or oesophagus. The risk of death is extremely low (0.05-0.1%). 2018;11(7):e006350.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

MAY 29, 2024

Data presented today by AstraZeneca , at the European Atherosclerosis Society (EAS) Congress in France, on AZD0780, an oral PCSK9 inhibitor demonstrated significant LDL-C reduction on top of statin in Phase I trial. Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6

Cholesterol 52

Cholesterol Cardiovascular Disease Atherosclerosis Myocardial Infarction 52

Stroke: Vascular and Interventional Neurology

OCTOBER 25, 2024

Longterm cardiac rhythm monitoring using insertable cardiac monitors (ICMs) has greater diagnostic yield compared with conventional monitoring in detecting AF, and the clinical utility of ICMs is established in cryptogenic stroke, strokes attributable to largeartery atherosclerosis, and strokes attributable to smallvessel disease.

Inpatient 40

Inpatient Atrial Fibrillation Stroke Strokes 40

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

ObjectiveMitochondrial dysfunction is associated with increased risk of atherosclerosis by disrupting key cellular processes that contribute to premature vascular ageing.

Coronary Artery Disease 52

Coronary Artery Disease Risk Factors Obesity Atherosclerosis 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Personalized Cardiometabolic Care TRANSFORM Program for Coronary Artery Disease (CAD) : The TRANSFORM program focuses on atherosclerosis-based care strategies rather than traditional risk-based approaches.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59